Heart Test Laboratories Inc (HSCS)

Dec 16, 2024, 4:15 PM EST - 4 weeks ago

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Nov 13, 2024, 9:00 AM EST - 2 months ago

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Oct 14, 2024, 4:15 PM EDT - 3 months ago

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 12, 2024, 4:15 PM EDT - 4 months ago

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Sep 12, 2024, 9:00 AM EDT - 4 months ago

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Jul 29, 2024, 4:05 PM EDT - 6 months ago

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Jul 26, 2024, 9:00 AM EDT - 6 months ago

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Jul 25, 2024, 8:30 AM EDT - 6 months ago

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Jul 11, 2024, 9:00 AM EDT - 6 months ago

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Jun 4, 2024, 4:15 PM EDT - 8 months ago

HeartSciences Regains Compliance with Nasdaq Listing Requirements

May 20, 2024, 9:00 AM EDT - 8 months ago

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

Apr 24, 2024, 9:00 AM EDT - 9 months ago

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Apr 2, 2024, 4:15 PM EDT - 10 months ago

HeartSciences to Present at the LD Micro Invitational XIV Conference

Mar 26, 2024, 9:00 AM EDT - 10 months ago

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Mar 14, 2024, 4:15 PM EDT - 11 months ago

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

Mar 12, 2024, 9:00 AM EDT - 11 months ago

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

Mar 6, 2024, 9:00 AM EST - 11 months ago

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

Feb 26, 2024, 9:00 AM EST - 11 months ago

HeartSciences Adds Key Advisor to its Scientific Advisory Board

Feb 12, 2024, 9:00 AM EST - 1 year ago

HeartSciences Expands its Scientific Advisory Board

Feb 1, 2024, 9:00 AM EST - 1 year ago

HeartSciences Appoints New Scientific Advisory Board Member

Jan 18, 2024, 8:00 AM EST - 1 year ago

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

Jan 3, 2024, 4:15 PM EST - 1 year ago

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

Dec 14, 2023, 4:15 PM EST - 1 year ago

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

Dec 5, 2023, 8:00 AM EST - 1 year ago

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

Nov 13, 2023, 8:45 AM EST - 1 year ago

HeartSciences' MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

Nov 3, 2023, 8:28 AM EDT - 1 year ago

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

ARQT SINT

Sep 14, 2023, 4:15 PM EDT - 1 year ago

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

Sep 12, 2023, 4:15 PM EDT - 1 year ago

HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase

Sep 11, 2023, 4:15 PM EDT - 1 year ago

HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards

Sep 7, 2023, 9:00 AM EDT - 1 year ago

HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India

Aug 31, 2023, 9:00 AM EDT - 1 year ago

HeartSciences Signs Distribution Agreement with FJ Medical, Denmark

Aug 24, 2023, 9:00 AM EDT - 1 year ago

HeartSciences' MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation

Aug 17, 2023, 9:00 AM EDT - 1 year ago

HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio

Jul 27, 2023, 9:00 AM EDT - 1 year ago

MyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark

Jul 19, 2023, 9:00 AM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results

May 17, 2023, 8:00 AM EDT - 1 year ago

HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine

May 9, 2023, 8:15 AM EDT - 1 year ago

HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG

May 8, 2023, 8:15 AM EDT - 1 year ago

HeartSciences to Participate at the Inaugural EF Hutton Global Conference

May 2, 2023, 8:15 AM EDT - 1 year ago

HeartSciences to Participate in The Benchmark Company's Virtual Individual Investor Healthcare Conference

Apr 17, 2023, 8:15 AM EDT - 1 year ago

HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023

Mar 16, 2023, 4:15 PM EDT - 2 years ago

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results

Feb 7, 2023, 11:04 AM EST - 2 years ago

HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time

Feb 6, 2023, 7:30 AM EST - 2 years ago

HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease

Feb 3, 2023, 9:00 AM EST - 2 years ago

HeartSciences Announces Further Internationalization of its Patent Portfolio

Jan 23, 2023, 9:00 AM EST - 2 years ago

Correction: HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th

Jan 20, 2023, 9:00 AM EST - 2 years ago

HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th

Jan 4, 2023, 9:00 AM EST - 2 years ago

HeartSciences Appoints David R. Wells to its Board of Directors, an Experienced Capital Markets and Finance Executive

Dec 16, 2022, 8:30 AM EST - 2 years ago

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results

Dec 1, 2022, 9:00 AM EST - 2 years ago

HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms

Nov 28, 2022, 9:00 AM EST - 2 years ago

HeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022